Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson's Disease

Lauren Heusinkveld1,2, Mallory Hacker1, Maxim Turchan1

  • 1Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.

Insights

Most early-stage Parkinson's disease patients are open to learning about deep brain stimulation (DBS) trials. This suggests potential for recruiting participants for invasive therapies aimed at slowing symptom progression.

Area of Science:

  • Neurology
  • Neurosurgery
  • Clinical Trials

Background:

  • Parkinson's disease (PD) is a progressive neurodegenerative disorder.
  • Deep brain stimulation (DBS) is an emerging invasive therapy for PD.
  • Early-stage PD patient enrollment in invasive therapy trials requires investigation.

Purpose of the Study:

  • To survey potential participants for a Phase III trial of DBS in early PD.
  • To identify motivating factors and barriers to trial participation.
  • To explore gender differences in patient considerations for DBS trials.

Main Methods:

  • A survey was conducted among individuals with early-stage PD.
  • The survey focused on motivations, barriers, and gender differences regarding DBS trial participation.
  • The study was conducted in partnership with The Michael J. Fox Foundation for Parkinson's Research.

Main Results:

  • 72% of survey respondents expressed willingness to learn more about trial participation.
  • Early-stage PD patients are likely to consider invasive therapy trials.
  • Motivating factors and barriers were identified, with gender differences noted.

Conclusions:

  • Early-stage Parkinson's disease patients are receptive to information about DBS clinical trials.
  • Patient willingness to consider invasive therapies suggests feasibility for trial recruitment.
  • Understanding patient perspectives is crucial for advancing PD treatment research.